IBS-C Treatment in Kids & Adults: New Drug Studies
Irritable bowel syndrome with constipation (IBS-C) is a disorder of gut-brain interaction characterized by infrequent, hard stools and recurrent abdomin…
Irritable bowel syndrome with constipation (IBS-C) is a disorder of gut-brain interaction characterized by infrequent, hard stools and recurrent abdomin…
The Gut-Brain Axis in Depression: A New Study Points to Bile Acids Hypericin, a compound from St
The Gut-Mammary Highway: How Breastmilk Transfers a Mother’s Microbiome Infants do not build their gut microbiomes from scratch
Introduction Managing irritable bowel syndrome with constipation (IBS-C) is moving from a one-size-fits-all approach to personalized treatment strategies
Hypericin’s Antidepressant Effect Fails Without a Healthy Gut Microbiome Researchers from Huazhong University of Science and Technology identified a spe…
Hypericin’s Antidepressant Effect Requires a Healthy Gut Microbiome A 2026 study from Huazhong University of Science and Technology provides direct expe…
Linaclotide Earns FDA Approval for Pediatric IBS-C Patients Aged 7 and Up For children and adolescents with irritable bowel syndrome with constipation (…
L-Glutamine for Gut Healing: Evidence from Burn Injury and the Intestinal Barrier L-glutamine, the most abundant amino acid in the blood, is marketed as…
Breaking the Pelvic Floor Stigma in IBS-C Management A 2026 Belgian consensus guideline published in Acta Gastroenterologica Belgica presents a clear me…
The Microbiome as a New Target for Cancer Therapy Two reviews published in 2026 reveal a complex molecular dialogue where gut bacteria directly modify t…
Why Treating IBS-C Often Means Looking Outside the Bowel A 2026 Belgian consensus guideline, developed by researchers at KU Leuven and University Hospit…
An Antidepressant’s Power Comes From the Gut, a 2026 Study Finds Researchers at Huazhong University of Science and Technology demonstrated that a natura…